ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Latest ARWR Insider Trades
About ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
- PASADENA, CA
- 711
- 1995
- XNAS
https://www.arrowheadpharma.comSEC filings for ARWR on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 13,600 | $1.19M |
| Grant or award | 1 | 11,882 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
ARWR Insider Transactions (Form 4)
4525 Form 4 filings on record, the earliest from Dec 18, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Adeoye Y. Olukotun - Director | Open-market sale | Common Stock | 2,000 |
Recent ARWR Form 8-K Filings
4Recent ARWR Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Adeoye Olukotun | Director | 2,000 | $174K | View on EDGAR | |
| Michael Perry | Director |
ARWR Insider Trading - FAQ
What is the latest insider trade for ARWR?
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had 3 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for ARWR runs to 25 Form 4 filings, the earliest from 2024-12-18. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ARWR stock?
No insider purchases of ARWR were filed in the last 90 days.
How many insiders are selling ARWR stock?
2 insider sales of ARWR were filed in the last 90 days, totaling $1.19M.
Where can I see ARWR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks ARWR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ARWR insider buys?
Create a free InsiderAlpha account and press Watch on this page to add ARWR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Adeoye Y. Olukotun view on EDGAR
- - Michael S. Perry view on EDGAR
- - Matthew Gregory Cohen view on EDGAR
- - Hongbo Lu view on EDGAR
- - Daniel Joseph Apel view on EDGAR
- - James C. Hamilton view on EDGAR
- - James C. Hamilton view on EDGAR
- - Christopher Richard Anzalone view on EDGAR
- - Mauro Ferrari view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where ARWR's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track ARWR insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
